⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RGEN News
Repligen Corp
Repligen Corporation to Present at Upcoming March Conferences
globenewswire.com
RGEN
Repligen Corporation to Present at Upcoming March Conferences
globenewswire.com
RGEN
Form 8-K
sec.gov
RGEN
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
globenewswire.com
RGEN
Preparative and Process Chromatography Market worth $21.50 billion by 2031 | MarketsandMarkets™
prnewswire.com
DHR
RGEN
TMO
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
[Latest] Global Large And Small Scale Bioprocessing Market Size/Share Worth USD 277.4 Billion by 2035 at a 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)
globenewswire.com
ECL
RGEN
MRK
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
RGEN
Limbal Stem Cell Deficiency Market Set to Transform During the Forecast Period (2025–2034) With Innovative Treatment Advances | DelveInsight
globenewswire.com
KALA
NOVM
OOMA
RGEN
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
globenewswire.com
ALVO
RGEN